Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
13,18 USD | +0,30% | -9,73% | -38,84% |
Omzet 2024 * | 2,66 mld. 2,5 mld. | Omzet 2025 * | 2,76 mld. 2,59 mld. | Marktkapitalisatie | 2,23 mld. 2,09 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -172 mln. -161 mln. | Nettowinst (verlies) 2025 * | -117 mln. -110 mln. | EV/omzet 2024 * | 0,94 x |
Nettoschuld 2024 * | 278 mln. 261 mln. | Nettoschuld 2025 * | 75,83 mln. 71,18 mln. | EV/omzet 2025 * | 0,84 x |
K/w-verhouding 2024 * |
-12,5
x | K/w-verhouding 2025 * |
-19,9
x | Werknemers | 5.208 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 99,23% |
Recentste transcriptie over Teladoc Health, Inc.
1 dag | +0,30% | ||
1 week | -9,73% | ||
Lopende maand | -12,72% | ||
1 maand | -12,83% | ||
3 maanden | -33,60% | ||
6 maanden | -28,45% | ||
Lopend jaar | -38,84% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Mala Murthy
CEO | Chief Executive Officer | 60 | 24-06-19 |
Jeff Nadler
CTO | Chief Tech/Sci/R&D Officer | - | 01-02-11 |
Nikolaos Nanis
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Snow
CHM | Chairman | 69 | 01-02-14 |
Sandra Fenwick
BRD | Director/Board Member | 73 | 19-11-20 |
David Shedlarz
BRD | Director/Board Member | 75 | 19-09-16 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
4.31% | 1 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
18-04-24 | 13,18 | +0,30% | 4 035 574 |
17-04-24 | 13,14 | +0,08% | 3 948 423 |
16-04-24 | 13,13 | -3,10% | 4 898 635 |
15-04-24 | 13,55 | -4,64% | 6 416 014 |
12-04-24 | 14,21 | -2,67% | 4 933 513 |
uitgestelde koers Nyse, 18 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-38,84% | 2,23 mld. | |
+38,65% | 2,64 mld. | |
+16,93% | 502 mln. | |
+42,77% | 467 mln. | |
-65,24% | 153 mln. | |
-33,67% | 82,92 mln. |